|
| |
net
| Symbol: | net | | Name(s): | net | | Type: | protein-coding | | Organism: | Drosophila melanogaster | | Synonyms: | CG11450, Group IId, Shout | | Links: |
Pubmed,
Entrez Gene,
Map Viewer.
|
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 17565966 |
Previous results indicated that netrin phenotype is epistatic to sli or robo phenotypes. However, it seems likely that this previously reported epistatic relationship might be due to the partial penetrance of the sli, robo, robo3 (or robo2) phenotypes. |
Press Releases on net:
|
 |
| Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians |
20th November, 2009 |
Louisiana Association of Health Plans |
BATON ROUGE, La., Nov. 20 /PRNewswire-USNewswire/ -- The Louisiana Association of Health Plans (LAHP) today warned that Louisianians could experience higher health care
|
| Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost |
20th November, 2009 |
Medco Health Solutions, Inc. |
NEW YORK, Nov. 20 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc (NYSE: MHS) is today contributing to a transformation in American healthcare through an advanced, wired pharmacy paradigm
|
| Reportlinker Adds Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 |
20th November, 2009 |
Reportlinker |
NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Biotel Announced Profitable First Quarter Ended September 30, 2009 |
20th November, 2009 |
Biotel Inc. |
MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL) announced results for its first quarter ended September 30, 2009 with net earnings of $128,000, or $0
|
| Novavax Prices Public Offering of Common Stock |
20th November, 2009 |
Novavax, Inc. |
ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has priced an underwritten public offering of 6,800,000 shares of its common stock at a
|
net results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for net,
or search for net on BioPortfolio's antibody search engine.
This page has been viewed 102 times
Recent Search Terms used to find this page: .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
